SCHEMBL28113527

SCHEMBL28113527

CCC(=O)c1cc(Cl)c(Cl)cc1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 1/20 0.56
HSP90AB1 P08238 1/20 0.55
HPGD P15428 4/20 0.47
ALDH1A1 P00352 4/20 0.47
HSD17B10 Q99714 3/20 0.47
TSHR P16473 2/20 0.47
ALOX15 P16050 2/20 0.47
RECQL P46063 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
CA9 Q16790 1/20 0.46
POLB P06746 1/20 0.46
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
CYP3A4 P08684 2/20 0.45
PTGS1 P23219 1/20 0.45
DRD3 P35462 1/20 0.45
KDM4E B2RXH2 3/20 0.39
LMNA P02545 3/20 0.39
MAPT P10636 2/20 0.39
HTT P42858 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15364117 0.90 HMGCR (0.55) HMGCRHSP90AB1HPGDALDH1A1HSD17B10
SCHEMBL4933019 0.86 HMGCR (0.51) HMGCRHSP90AB1HPGDALDH1A1HSD17B10
SCHEMBL4936413 0.86 HMGCR (0.51) HMGCRHSP90AB1HPGDALDH1A1HSD17B10
SCHEMBL29368097 0.85 HMGCR (0.50) HMGCRHSP90AB1HPGDALDH1A1HSD17B10
SCHEMBL22804304 0.85 HMGCR (0.50) HMGCRHSP90AB1HPGDALDH1A1HSD17B10
SCHEMBL29368970 0.85 HMGCR (0.50) HMGCRHSP90AB1HPGDALDH1A1HSD17B10
SCHEMBL22622554 0.85 HMGCR (0.50) HMGCRHSP90AB1HPGDALDH1A1HSD17B10
SCHEMBL19425899 0.83 HSP90AB1 (0.50) HMGCRHSP90AB1HPGDALDH1A1HSD17B10
SCHEMBL27980024 0.82 HMGCR (0.47) HMGCRHSP90AB1HPGDALDH1A1HSD17B10
SCHEMBL28167755 0.82 HMGCR (0.75) HMGCRHSP90AB1HPGDALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106986867-B Heterocycle amine as PI3K inhibitor 因塞特控股公司 2019-06-28 CN disclosed
CN-109010343-A The purposes of Pyrazolopyrimidine derivative treatment PI3K δ associated disease 因赛特公司 2018-12-18 CN disclosed
CN-105120871-B Use of pyrazolopyrimidine derivatives for the treatment of PI 3K-related disorders 因赛特公司 2018-08-10 CN disclosed
CN-106986867-A It is used as the heterocyclic radical amine of PI3K inhibitor 因塞特控股公司 2017-07-28 CN disclosed
CN-104024253-B Heterocyclic amines as PI3K inhibitors INCYTE HOLDINGS CORP. (US) 2016-11-30 CN disclosed